Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

ClinicalTrials.gov ID: NCT02290028

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02290028. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:52 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The QP ExCELs study is designed to confirm safety and efficacy of the BIOTRONIK Sentus OTW QP left ventricular leads to satisfy FDA requirements for regulatory approval of the leads in the US. The Sentus OTW QP leads received FDA approval on May 4, 2017. Long-term safety of the BIOTRONIK Sentus OTW QP left ventricular leads will be confirmed during the ongoing post approval phase (US sites only). A protocol update was implemented on September 6, 2019 to transition the long-term follow up for the ongoing Sentus QP Study to a new EP PASSION real-world data methodology.

Study identification

NCT ID: NCT02290028
Recruitment status: Terminated
Study type: Interventional
Phase: Not applicable
Lead sponsor: Biotronik SE & Co. KG; Industry
Enrollment: 2,226 participants

Conditions and interventions

Conditions

Heart Failure

Interventions

Sentus QP left ventricular lead Device

Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 16, 2014 (Actual)
Primary completion: Jan 23, 2020 (Actual)
Completion: Jan 23, 2020 (Actual)
Last update posted: Mar 24, 2021

2014 – 2020

United States locations

U.S. sites: 75
U.S. states: 34
U.S. cities: 67

Facility	City	State	ZIP	Site status
Not listed	Fairhope	Alabama	—	—
Not listed	Anchorage	Alaska	—	—
Not listed	Chula Vista	California	—	—
Not listed	Inglewood	California	—	—
Not listed	Rancho Mirage	California	—	—
Not listed	Aurora	Colorado	—	—
Not listed	Washington D.C.	District of Columbia	—	—
Not listed	Orlando	Florida	32803	—
Not listed	Orlando	Florida	32806	—
Not listed	Pensacola	Florida	—	—
Not listed	Tampa	Florida	33613	—
Not listed	Atlanta	Georgia	—	—
Not listed	Chicago	Illinois	—	—
Not listed	Joliet	Illinois	—	—
Not listed	Fort Wayne	Indiana	—	—
Not listed	Iowa City	Iowa	—	—
Not listed	Kansas City	Kansas	—	—
Not listed	Lexington	Kentucky	40503	—
Not listed	Lexington	Kentucky	40536	—
Not listed	New Orleans	Louisiana	—	—
Not listed	Bangor	Maine	—	—
Not listed	Boston	Massachusetts	—	—
Not listed	Burlington	Massachusetts	—	—
Not listed	Fall River	Massachusetts	—	—
Not listed	Worcester	Massachusetts	—	—
Not listed	Ann Arbor	Michigan	—	—
Not listed	Detroit	Michigan	—	—
Not listed	Ypsilanti	Michigan	—	—
Not listed	Tupelo	Mississippi	—	—
Not listed	Kansas City	Missouri	—	—
Not listed	Saint Charles	Missouri	—	—
Not listed	Springfield	Missouri	—	—
Not listed	St Louis	Missouri	63110	—
Not listed	St Louis	Missouri	63136	—
Not listed	Kalispell	Montana	—	—
Not listed	Browns Mills	New Jersey	—	—
Not listed	Englewood	New Jersey	—	—
Not listed	Hackensack	New Jersey	—	—
Not listed	Neptune City	New Jersey	—	—
Not listed	Brooklyn	New York	—	—
Not listed	Flushing	New York	—	—
Not listed	New York	New York	10016	—
Not listed	New York	New York	10021	—
Not listed	New York	New York	10025	—
Not listed	New York	New York	10029	—
Not listed	The Bronx	New York	—	—
Not listed	Valhalla	New York	—	—
Not listed	Asheville	North Carolina	—	—
Not listed	Chapel Hill	North Carolina	—	—
Not listed	Greensboro	North Carolina	—	—
Not listed	Greenville	North Carolina	—	—
Not listed	Winston-Salem	North Carolina	27103	—
Not listed	Winston-Salem	North Carolina	27157	—
Not listed	Fargo	North Dakota	—	—
Not listed	Cincinnati	Ohio	45219	—
Not listed	Columbus	Ohio	43210	—
Not listed	Columbus	Ohio	43214	—
Not listed	Toledo	Ohio	43615	—
Not listed	Bryn Mawr	Pennsylvania	—	—
Not listed	Philadelphia	Pennsylvania	—	—
Not listed	Wynnewood	Pennsylvania	—	—
Not listed	Warwick	Rhode Island	—	—
Not listed	Anderson	South Carolina	—	—
Not listed	Columbia	South Carolina	—	—
Not listed	Greenville	South Carolina	—	—
Not listed	Chattanooga	Tennessee	—	—
Not listed	Amarillo	Texas	—	—
Not listed	Fort Worth	Texas	—	—
Not listed	San Antonio	Texas	—	—
Not listed	The Woodlands	Texas	—	—
Not listed	Salt Lake City	Utah	—	—
Not listed	Burlington	Vermont	—	—
Not listed	Norfolk	Virginia	—	—
Not listed	Milwaukee	Wisconsin	—	—
Not listed	Cheyenne	Wyoming	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02290028, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 24, 2021 · Synced Nov 14, 2026